ASCO Coronavirus Resources

As the nation continues to respond to the coronavirus (COVID-19) pandemic, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that individuals with cancer receive high-quality care.

ASCO has compiled a wide range of resources to support clinicians, the cancer care delivery team, and patients with cancer. This is a rapidly evolving situation and ASCO resources will be updated on a regular basis. Please continue to check back for the most current information. We are united in working together to continue the critical work of conquering cancer during this health care crisis.

ASCO and Conquer Cancer would like to thank the below donors for generously funding The COVID Impacts Cancer Fund.

Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol Myers Squibb
Daiichi Sankyo, Inc.
Exelixis, Inc.
Genentech BioOncology TM
Gilead Sciences, Inc.
Incyte Corporation
Janssen Pharmaceutical Companies of Johnson & Johnson
Merck & Co., Inc.
Novartis Oncology
Pfizer Oncology
​TAIHO Oncology, Inc.
Takeda Oncology

Random Quote

"Precision medicine has begun to transform the lives of many patients with cancer, but its application in clinical practice is enormously complex. ASCO hopes to contribute to and advance the field by providing oncologists with the training, tools, and data they need."
Richard L. Schilsky, MD, FACP, FASCO
ASCO Chief Medical Officer